The obviousness rejection as a barrier to vaccine patent prosecution: Commentary

Human Vaccines

Volumn 7, Issue 4, 2011, Pages

  Wang, Shyh Jen ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Adjuvant; Isolated DNA; Obviousness; Patent; Patentability

Indexed keywords

CD48 ANTIGEN; COMPLEMENTARY DNA; NATURAL KILLER CELL ACTIVATION INDUCING LIGAND POLYPEPTIDE; POLYPEPTIDE; UNCLASSIFIED DRUG; VACCINE;

AMINO ACID SEQUENCE; DNA ISOLATION; DNA SEQUENCE; GOVERNMENT REGULATION; HUMAN; JURISPRUDENCE; MOLECULAR CLONING; NOTE; PATENT; PREDICTION; PROTEIN BINDING; PROTEIN FUNCTION; PUBLIC OPINION; IMMUNOLOGY; LEGAL ASPECT; MOLECULAR BIOLOGY; REVIEW;

HUMANS; MOLECULAR BIOLOGY; PATENTS AS TOPIC; VACCINES;

EID: 82255173497     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.7.4.14134     Document Type: Note

References (12)

1. Schechter R, Thomas J. Principles of patent law. St. Poul, MN: West, a Thomson business, 2004.
2. Pressman D. Patent it yourself. Berkeley, CA: Nolo. com, 2000.
3. Wang S-J. The obviousness rejection as a barrier to biotech patent prosecution. Nature Biotechnology 2009; 27:1125-6.
4. KSR Int'l Co. v. Teleflex, Inc.: US Supreme Court, 2007.
5. In re Kubin. the United States Court of Appeals for the Federal Circuit, 2009.
6. Sambrook J, Russell D. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
7. Mathew P, Garni-Wagner B, Land K, Takashima A, Stoneman E, Bennett M, et al. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells Journal of Immunology 1993; 151:5328-37.
8. General Electric Co. v. Jewel Incandescent Lamp Co., . The US Supreme Court, 1945.
9. In re Wiseman. the United States Court of Customs and Patent Appeals, 1979.
10. In re O'Farrell. the United States Court of Appeals for the Federal Circuit, 1988.
11. Hoffenberg H. Will the patentability of genes survive? Nature Biotechnology 2010; 28:925-6.
12. Interven Inc. v. Merial Ltd. . the United States Court of Appeals for the Federal Circuit 2010.